Viktor Kopylov, PhD, CFA - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Viktor Kopylov, PhD, CFA

Viktor Kopylov, PhD, CFA

Creator
0 followers

Macro strategist posting on USD/rates/PMIs that directly affect cross‑commodity pricing across energy, metals, and agriculture.

Recent Posts

DHS Funding Gap Pauses Global Entry, Sparks Airline Buy
Social•Feb 22, 2026

DHS Funding Gap Pauses Global Entry, Sparks Airline Buy

Macro: DHS funding lapse prompted policy reversals. Key: TSA PreCheck remains; Global Entry paused. Risk: service uncertainty may boost travel volatility. Trade: buy select airline stocks. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
AI Surge Boosts HBM Demand; Buy MU on Dips
Social•Feb 21, 2026

AI Surge Boosts HBM Demand; Buy MU on Dips

Macro: AI demand drives chip & platform leaders. Factors: HBM tightness (Micron), AIP adoption (Palantir). Risks: supply, concentration. Trade: buy MU on pullbacks for HBM exposure. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Buy ONON as SCOTUS Limits IEEPA Tariff Upside
Social•Feb 21, 2026

Buy ONON as SCOTUS Limits IEEPA Tariff Upside

Macro: SCOTUS struck down IEEPA tariffs; admin will likely reissue ~80–90% → limited upside. Key: supplier pricing, de minimis. Risk: refunds slow. Trade: buy ONON for margin tailwind. 📈 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
10% Market Slide Could Wipe $
Social•Feb 21, 2026

10% Market Slide Could Wipe $

10% equity drop could erase $7T and shave ~0.9% off GDP. Tech/AI capex and hyperscaler overinvestment raise downside risk. Trade insight: trim cyclicals & hardware suppliers. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
HSBC Cuts US DCM, Shifts Focus to Asian Banks
Social•Feb 20, 2026

HSBC Cuts US DCM, Shifts Focus to Asian Banks

Macro: HSBC trims ~10% of US DCM in broader $1.8bn cost overhaul and pivot to Asia/Middle East. Key factors: management cuts, M&A/ECM pullback. Risk: execution/credit cycles. Trade: favor Asian bank equities. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Buy Newmont on Pullbacks as Gold Rises
Social•Feb 19, 2026

Buy Newmont on Pullbacks as Gold Rises

Macro: gold up on rate‑cut hopes & geopolitics. Key: Newmont beat as realized $4,216/oz offset 24% output drop. Risk: output erosion, volatility. Trade: buy Newmont on pullbacks. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Nikkei Rises; Buy Nikkei ETF Amid FX Risks
Social•Feb 19, 2026

Nikkei Rises; Buy Nikkei ETF Amid FX Risks

Nikkei +0.71%; real estate, banks, textiles led; VIX-Nikkei 27.89. Leaders: Yokohama Rubber, Omron. Risks: FX (USD/JPY 155.11), commodity shocks. Trade: buy Nikkei ETF. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
US Vaccine Policy Shift Boosts MRNA Stock Appeal
Social•Feb 18, 2026

US Vaccine Policy Shift Boosts MRNA Stock Appeal

Macro: US vaccine-policy swing heightens regulatory risk; FDA will review Moderna’s flu shot. Key: public dispute, amended filing; decision by Aug 5. Risk: political oversight. Trade: Buy MRNA. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Global Growth Slows, Rates Sticky; Shorten Treasury Duration
Social•Feb 18, 2026

Global Growth Slows, Rates Sticky; Shorten Treasury Duration

Macro: global growth slows; rates remain sticky. Key factors: US CPI, China demand, energy. Risks: policy missteps, inflation shocks. Trade: shorten duration in US Treasuries. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
RUB Strengthens as Oil Stabilizes, Gold Surges
Social•Feb 14, 2026

RUB Strengthens as Oil Stabilizes, Gold Surges

Macro: MOEX flat as oil steadies and gold spikes; RUB strengthens (USD/RUB 76.65). Key drivers: commodity moves, stable RVI (24.9). Risks: commodity volatility, sanctions. Trade: buy selective energy exporters on RUB resilience. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Buy Manappuram on Pullbacks Amid RBI
Social•Feb 14, 2026

Buy Manappuram on Pullbacks Amid RBI

Macro: PE flows target Indian NBFCs. RBI cleared Bain's up to 41.7% in Manappuram; ₹43.85bn injected. Risk: regulatory scrutiny. Trading insight: buy Manappuram on pullbacks. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Politicized Asset Stewardship Spurs Lease Cancellations, REIT Shorts
Social•Feb 14, 2026

Politicized Asset Stewardship Spurs Lease Cancellations, REIT Shorts

Macro: politicized stewardship of public assets rising; Key: Interior canceled NLT lease; Risk: litigation & environmental hurdles delay projects; Trade: short park‑adjacent REITs. ⚖️ — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
Growth Slows, Yields Rise—Short Treasury Duration
Social•Feb 10, 2026

Growth Slows, Yields Rise—Short Treasury Duration

Macro: growth softens, yields rise. Key: sticky CPI, Fed tightening, tight labor. Risks: stagflation, policy error. Trade: short US Treasury duration as real yields climb. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA